Human Papillomavirus Typing of Rare Cervical Carcinomas

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 5, 2004, Pages 553-556

  Matthews Greer, Janice ^a   Dominguez Malagon, Hugo ^b   Herrera, Guillermo A ^a   Unger, James ^a   Chanona Vilchis, José ^b   Caldito, Gloria ^a   Turbat Herrera, Elba A ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; FEMALE; GYNECOLOGIC CANCER; HISTOLOGY; HUMAN; MEXICO; NONHUMAN; POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; VIRUS TYPING; WART VIRUS;

CARCINOMA; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

EID: 2342593336     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180:1415-1423.
2. Bosch FX, Mano MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
3. Lazcano-Ponce E, Herrero R, Munoz N, et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001;91:412-420.
4. Peyton CL, Gravitt PE, Hunt WC, et al. Determinants of genital human papillomavirus detection in a US population. J Infect Dis. 2001;183:1554-1564.
5. Liaw K-L, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis. 2000;183:8-15.
6. Andersson S, Rylander E, Larsson B, Strand A, Silfversvard C, Wilander E. The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer. 2001;37:246-250.
7. Nagai Y, Maehama T, Asato T, Kanazawa K. Detection of human papillomavirus DNA in primary and metastatic lesions of carcinoma of the cervix in women from Okinawa, Japan. Am J Clin Oncol. 2001;24:160-166.
8. Pirog EC, Kleter B, Olgac S, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 2000;157:1055-1062.
9. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Loning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer. 1995;63:639-645.
10. Clavel C, Masure M, Levert M, et al. Human papillomavirus detection by the Hybrid Capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol. 2000;9:145-150.
11. Wallin KL, Wiklund F, Angstrom R, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med. 1999;341:1633-1638.
12. Gravitt PE, Peyton CI, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357-361.
13. Jacobs MV, Husman AM, van den Brule AJ, Snijders PJ, Meijer CJ, Walboomers JM. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol. 1995;33:901-905.
14. Kleter B, van Doorn L-J, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol. 1999;37:2508-2517.
15. Mant C, Kell B, Best JM, Cason J. Polymerase chain reaction protocols for the detection of DNA from mucosal human papillomavirus types-6, -11, -16, -18, -31, and -33. J Virol Methods. 1997;66:169-178.
16. Bernard HU, Chan SY, Manos M, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence and phylogenetic algorithms. J Infect Dis. 1994;170:1077-1085.
17. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GPS+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997;35:791-795.
18. Nelson JH, Hawkins GA, Edlund K, et al. A novel and rapid PCR-based method for genotyping human papillomaviruses in clinical samples. J Clin Microbiol. 2000;38:688-695.
19. Baay MF, Quint WG, Koudstaal J, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol. 1996;34:745-747.
20. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998;36:3020-3027.
21. Terai M, Burk RD. Complete nucleotide sequence and analysis of a novel human papillomavirus (HPV 84) genome cloned by an overlapping PCR method. Virology. 2001;279:109-115.
22. Thomas KK, Hughes JP, Kuypers JM, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis. 2000;182:1097-1102.